Lercanidipine/valsartan - LG Chem
Alternative Names: Levacalm; Valsartan/lercanidipineLatest Information Update: 05 Feb 2019
At a glance
- Originator LG Life Sciences
- Developer LG Chem
- Class Antihypertensives; Branched-chain amino acids; Dihydropyridines; Small molecules; Tetrazoles
- Mechanism of Action Angiotensin type 1 receptor antagonists; Calcium channel antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Essential hypertension
Most Recent Events
- 05 Feb 2019 Chemical structure information added
- 01 Aug 2013 Launched for Essential hypertension in South Korea (PO) (LG Life Sciences website, April 2016)
- 01 Jul 2013 Registered for Essential hypertension in South Korea (PO) (NCT02415192)